Eganslot4362

Microfluidics has become a reliable platform for circulating tumor cells (CTCs) detection because of its high integration, small size, low consumption of reagents and rapid response. Here, we developed a multifunctional microfluidic device consists of three parts, including CTCs capture area, single-layer membrane valves area, and microcavity nucleic acid detection and analysis region based on digital polymerase chain reaction (dPCR), allowing CTCs capture, lysis, and genetic characterization to be performed on a single chip. The CTCs capture chip is coupled to the nucleic acid detection chip via a control valve. CTCs were firstly trapped in the CTC capture area, and then lysed using proteinase K to release nucleic acids. Subsequently CTCs lysate was transferred into nucleic acid detection area consisting of 12800 micro-cavity chambers for nucleic acids detection. To evaluate the performance of this chip, this study detected EGFR-L858R mutation in lung cancer cell lines H1975 and A549 cells, as well as leukocytes from normal donors. The results showed that positive signals were only observed in H1975 cells, and the detected value had a high linear relationship with the expected value (R2 = 0.9897). In conclusion, this multi-functional microfluidic chip that integrates CTCs capture, lysis and nucleic acid detection can successfully detect gene mutations in CTCs, providing reference for tumor-targeted drugs and precise diagnosis and treatment.The determination of low abundant endogenous components is a challenge for the clinical samples. Histamine, a crucial endogenous component, fulfils various regulatory and mediatory functions in human, and the change of content is a critical index for the diagnosis of some diseases, especially allergy, asthma, and anaphylactic shock. However, it is challenging to detect histamine because of the low stability and concentration in complex biological samples. Here we developed an ultra-sensitive and accurate LC-MS/MS quantification method based on derivatization, isotope dilution, and solid phase extraction. The derivatization of histamine with diisopropyl phosphite (DIPP) not only enhanced the retention on the LC column but also improved the ionization efficiency. Next, solid phase extraction was applied to remove the interference, which finally resulted in standing out of the trace histamine from the high contents of the matrix. The lowest limit of quantification (LLOQ) was 0.1 pg/mL that is enough low to determine the histamine in one cell and low nano-liter of serum. This approach was successfully applied for the quantification of histamine in clinical serum samples of asthma patients and mast cell treated with chemicals modulating histamine release.Matrix metalloproteinase 9 (MMP-9) is a zinc-dependent endopeptidase that promotes angiogenesis, tumor growth, metastasis and cell invasion through the degradation of extracellular matrix. This work reports a magnetic microbeads (MBs)-based sandwich immunoassay for the amperometric determination of MMP-9 at screen-printed carbon electrodes (SPCEs). The suitable capture antibody (cAb) is immobilized onto carboxylic MBs to selectively capture the antigen which is sandwiched with a biotinylated detector antibody (biotin-dAb) further conjugated with a commercial streptavidin-horseradish peroxidase (Strep-HRP) polymer. This immunoplatform provides great analytical characteristics in terms of selectivity and sensitivity, achieving a LOD value of 2.4 pg mL-1 for standards in buffered solutions. Although this value is similar to those reported for some other approaches described so far, the method described here is simpler involving a single 30 min incubation step which makes it ideal for automation or implementation in POC devices. Antineoplastic and Immunosuppressive Antibiotics chemical Moreover, the method was assayed for the accurate determination of endogenous MMP-9 in both cancer cell lysates and serum samples of patients diagnosed with different subtypes of breast cancer (BC) after a simple dilution. The results obtained show that the disposable and affordable immunoplatform developed is able not only to discriminate BC patients from healthy individuals but also to do it for the worst outcome triple negative (TNBC) subtype.Green analytical chemistry principles should be followed, as much as possible, and particularly during the development of analytical sample preparation methods. In the past few years, outstanding materials such as ionic liquids, metal-organic frameworks, carbonaceous materials, molecularly imprinted materials, and many others, have been introduced in a wide variety of miniaturized techniques in order to reduce the amount of solvents and sorbents required during the analytical sample preparation step while pursuing more efficient extraction methods. Among them, magnetic nanomaterials (MNMs) have gained special attention due to their versatile properties. Mainly, their ability to be separated from the sample matrix using an external magnetic field (thus enormously simplifying the entire process) and their easy combination with other materials, which implies the inclusion of a countless number of different functionalities, highly specific in some cases. Therefore, MNMs can be used as sorbents or as magnetic support for other materials which do not have magnetic properties, the latter permiting their combination with novel materials. The greenness of these magnetic sorbents in miniaturized extractions techniques is generally demonstrated in terms of their ease of separation and amount of sorbent required, while the nature of the material itself is left unnoticed. However, the synthesis of MNMs is not always as green as their applications, and the resulting MNMs are not always as safe as desired. Is the analytical sample preparation field ready for using green magnetic nanomaterials? This review offers an overview, from a green analytical chemistry perspective, of the current state of the use of MNMs as sorbents in microextraction strategies, their preparation, and the analytical performance offered, together with a critical discussion on where efforts should go.Drugs in the bloodstream are available in both free and bound forms in which the free drug is responsible for pharmacological activities. Since protein binding determines the amount of free concentration of the drug in the blood, determining the protein binding in the early stages of drug discovery and development is of great importance. Besides, it is most beneficial to measure the free concentration of a drug in personalized medicine and therapeutic drug monitoring. For this reason, the need for sensitive, selective, and fast analytical methods to measure the free concentration of drugs and their protein binding has increased. This review aims to summarize recent advancements in analytical approaches used for the determination of free drug concentration and plasma protein binding and will focus on the most important approaches used to determine plasma protein binding. Furthermore, the concepts of each method will be described and discussed, along with their inherent advantages and disadvantages.